Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update

Go back to Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
(NYSE: NSRX) Delayed: 3.74 --0 (-0%)
Previous Close $3.74    52 Week High
Open $3.74    52 Week Low
Day High $3.74    P/E N/A 
Day Low $3.74    EPS
Volume 53